Frequently lost in the policy discussions
about human embryonic stem cells research are concrete realities that will determine how quickly such research will result in treatments and cures.
A new study confirms a seemingly obvious assumption
about human embryonic stem cell research: Countries with fewer restrictions on research outperform countries with more restrictions.
Not exact matches
Peter Tatchell,
human rights campaigner, talked
about Catholic dissent from the Pope's hardline, intolerant opposition to liberation theology, women's rights, gay equality, contraception, fertility treatment,
embryonic stem cell research and the Pope's collusion with Holocaust deniers and appeasers.
Yesterday, the same day an appeals court questioned lawyers
about the case, the government filed documents in a lower court arguing that the lawsuit brought by two researchers who oppose
human embryonic stem cell (hESC)
research should be thrown out.
Anger
about prospects for
human embryonic stem -
cell research might similarly attenuate if practical applications emerge.
I pray for the day when James A. Thomson and others in favor of
human embryonic stem cell research think
about it enough to be totally uncomfortable.
University of Wisconsin scientist, James A. Thomson, who first derived ESCs from embryos, has said «if
human embryonic stem cell research does not make you at least a little bit uncomfortable, you have not thought
about it enough.»
Wicker, no political naïf, brought out the big rhetorical ammo, reminding the senators that it was Jamie Thomson, the University of Wisconsin scientist who first reported isolating the
cells in 1998, who said: «If
human embryonic stem cell research does not make you at least a bit uncomfortable, you have not thought
about it enough.»
The
stem cell research community hopes that as more is understood
about STAP
cells, they will join
embryonic stem and iPS
cells as another reprogramming tool for use in their collective quest to understand and treat
human disease.
Last week, a ruling by federal Judge Royce C. Lamberth left many
human embryonic stem cell (hESC) researchers not only scrambling for funding and concerned
about the future of their own
research, but also concerned for the future of the whole field in this country.
The Society believes that
research involving the transfer of a
human nucleus into an animal egg will lead to important new knowledge
about cell nuclear replacement (CNR) technology and, if it were to prove possible to produce
embryonic stem cells by this route, would increase understanding of how to programme these
cells to develop into different tissue types.
Without these two technologies that you'll hear
about in a moment, there would be no such thing as
human embryonic stem cell research, and President Bush could have enjoyed his summer vacation in Crawford without having to agonize over the baptism of the infamous 64
stem cell lines.